• Viral RIPK3 Degradation and Inflammation: Immunity Study

  2026-10-06

  Liu and colleagues identified a viral inducer of RIPK3 degradation, or vIRD, that connects orthopoxvirus immune evasion with host SCF ubiquitin-ligase activity and proteasomal turnover. The study shows that vIRD can reshape necroptosis, viral replication, inflammation, and disease severity in genetically defined mouse models, while also highlighting the limits of extending these findings to human infection or unrelated apoptosis-focused systems.

• VER 155008 and HSP70: Evidence and Research Context

  2026-10-06

  VER 155008 is an adenosine-derived small-molecule HSP 70 inhibitor used as a research tool for studying chaperone-dependent signaling. This overview compares supplier-reported cancer findings with peer-reviewed evidence connecting HSC70 ATPase activity to transmissible gastroenteritis virus entry, while clarifying the limits of translating either evidence stream into antiviral or anticancer conclusions.

• HDAC Inhibition Reverses EBV-Linked NPC Dedifferentiation

  2026-10-05

  Xie et al. identify an epigenetic pathway through which EBV LMP1 promotes dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma. The study links LMP1 to STAT5A-dependent recruitment of HDAC1/2 at the CEBPA locus and shows that HDAC inhibition can restore differentiation-associated features in cellular and xenograft models.

• hiPSC Sensory Neurons Model HSV-1 Latency

  2026-10-04

  Oh and colleagues developed a scalable human iPSC-derived sensory-neuron system that reproduces several molecular hallmarks of HSV-1 latency and supports stimulus-induced reactivation. The study provides a human neuronal model for mechanistic virology, while its findings remain bounded by the differences between cultured neurons, sensory ganglia, and infection in people.

• SN-38, FUBP1, and FUSE Binding in Cancer

  2026-10-03

  The reference study identifies a mechanism beyond canonical topoisomerase I inhibition: camptothecin and SN-38 can interfere with binding of the oncogenic transcriptional regulator FUBP1 to its single-stranded DNA target, FUSE. The findings connect drug screening, biochemical interaction assays, and transcriptional effects in hepatocellular carcinoma models, while also highlighting important limits on extrapolation to colorectal cancer.

• AST 487 for KDM4A Dependency Studies

  2026-10-02

  AST 487 provides a practical pharmacologic entry point for testing whether malignant pleural mesothelioma cells depend on KDM4A activity. This workflow combines dose-response phenotyping with genetic validation, apoptosis measurements, and rational combination testing rather than relying on a single viability endpoint.

• From Reporter mRNA to Lung-Targeted LNPs

  2026-10-01

  A translational framework for using reporter mRNA to connect lipid structure, lung-selective delivery, and therapeutic development.

• 3X (DYKDDDDK) Peptide: Evidence & Workflow

  2026-10-01

  The 3X (DYKDDDDK) Peptide is a compact, hydrophilic FLAG epitope reagent for recombinant-protein detection, affinity purification, and structural workflows. Its reported solubility, storage requirements, antibody recognition, and metal sensitivity define practical conditions for reliable use.

• Osteoblast ECM1 and Anti-Androgen Resistance in Bone PCa

  2026-09-30

  This study identifies osteoblast-derived ECM1 as a microenvironmental driver of enzalutamide resistance in bone metastatic prostate cancer. It connects ECM1 to ENO1 phosphorylation, GRB2–SOS1 recruitment, and MAPK activation, while showing that ECM1 or ENO1 inhibition can restore enzalutamide sensitivity.

• 8-Chloroadenosine for RNA Turnover Assays

  2026-09-30

  8-Chloroadenosine offers a practical way to interrogate RNA synthesis alongside lncRNA-mediated transcript stability. This guide translates recent NSCLC RNA biology into a rigorous assay strategy for transcriptional regulation research, RNA metabolism studies, and cancer research.

• Geneticin: A Decision Framework for Cell Selection

  2026-09-29

  Geneticin and G418 Sulfate are more than selection antibiotics. This guide connects ribosomal inhibition, stable-cell assay design, and context-specific Dengue virus inhibition while translating recent PPGL research into practical workflow decisions.

• Fluorouracil and the Next Layer of Tumor Biology

  2026-09-29

  Fluorouracil remains a powerful translational tool because its direct effects on thymidylate synthase, nucleotide supply, and DNA replication can be connected to the broader biology of solid tumors. This thought-leadership article places 5-Fluorouracil in a strategic framework spanning colon cancer research, breast cancer research, apoptosis, Wnt/β-catenin signaling, and immune context—while distinguishing established evidence from forward-looking hypotheses.

• SMYD2, miR-125b, and Drug Resistance in RCC

  2026-09-28

  The reference study identifies SMYD2 as a prognostic epigenetic driver of clear cell renal cell carcinoma and connects its activity to the miR-125b/DKK3 axis and P-glycoprotein-mediated multidrug resistance. Its integrated patient, molecular, cellular, and xenograft evidence provides a framework for studying how SMYD2 inhibition may improve responses to conventional anticancer drugs.

• H. pylori Silences HNF4A to Promote Gastric Cancer

  2026-09-28

  A 2025 study links Helicobacter pylori infection to promoter hypermethylation and silencing of HNF4A, a gastric epithelial tumor suppressor. The findings connect this epigenetic change to loss of epithelial polarity, TGFβ-associated EMT signaling, and gastric cancer progression, while identifying a mechanistic framework for further validation.

• PNU 74654: Practical Wnt Pathway Assay Guide

  2026-09-27

  A practical guide to using PNU 74654 (SKU B7422) in cell viability, proliferation, and signaling experiments. It covers solvent handling, controls, interpretation, evidence limits, and supplier-selection criteria for Wnt/β-catenin research.

8576 records 1/572 page Next 12345 下5页 Last page